A detailed history of Arlington Trust CO LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Arlington Trust CO LLC holds 2,631 shares of JNJ stock, worth $408,252. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,631
Previous 2,702 2.63%
Holding current value
$408,252
Previous $394,000 8.12%
% of portfolio
0.09%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$145.48 - $167.38 $10,329 - $11,883
-71 Reduced 2.63%
2,631 $426,000
Q2 2024

Aug 06, 2024

BUY
$144.38 - $157.78 $140,770 - $153,835
975 Added 56.46%
2,702 $394,000
Q1 2024

Apr 16, 2024

SELL
$155.22 - $162.74 $76,678 - $80,393
-494 Reduced 22.24%
1,727 $273,000
Q4 2023

Jan 24, 2024

SELL
$145.6 - $158.88 $2.41 Million - $2.63 Million
-16,582 Reduced 88.19%
2,221 $348,000
Q3 2023

Oct 24, 2023

BUY
$155.75 - $174.48 $2.93 Million - $3.28 Million
18,803 New
18,803 $2.93 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Arlington Trust CO LLC Portfolio

Follow Arlington Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Trust CO LLC with notifications on news.